Expression of moesin and its associated molecule CD44 in epithelial skin tumors

被引:13
作者
Ichikawa, T
Masumoto, J
Kaneko, M
Saida, T
Sagara, J
Taniguchi, S
机构
[1] Shinshu Univ, Sch Med, Dept Mol Oncol & Angiol, Angioaging Res Div,Res Ctr Aging & Adaptat, Matsumoto, Nagano 390, Japan
[2] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan
关键词
D O I
10.1111/j.1600-0560.1998.tb01727.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Moesin, one of the ERM (ezrin; radixin; moesin) family members, is directly associated with the cytoplasmic domain of CD44, which is now thought to be related to the metastatic potential of tumor cells. Using immunohistochemistry we investigated the expression of moesin in normal epidermis and various kinds of epithelial skin tumors: squamous cell carcinoma, verrucous carcinoma, Bowen's disease, solar keratosis, keratoacanthoma, basal cell carcinoma, and extramammary Paget's disease. Normal skin showed positive epidermal staining for moesin with the exception of the stratum corneum. The expression of moesin varied with the type of skin tumor. In basal cell carcinoma, Bowen's disease, and extramammary Paget's disease, moesin expression was either faint or negative. In contrast to Bowen's disease, invasive squamous cell carcinoma showed more intense and heterogeneous staining of the cytoplasm and the cell membrane. Verrucous carcinoma was weakly positive, with a tendency for the moesin to be distributed in the cell membrane. The staining pattern of moesin varied among the different kinds of epithelial skin tumors, and its expression was generally similar to that of the standard form of CD44. These results suggest that moesin is closely inter-related with CD44 in epithelial skin cells as seen in other cellular systems, and that the variable pattern of moesin staining among the skin tumor cells could reflect expression disorders associated with the transformation.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 29 条
[1]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]   Expression of CD44 isoforms in basal cell carcinomas [J].
Baum, HP ;
Schmid, T ;
Shock, G ;
Reichrath, J .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (03) :465-468
[3]  
BERRYMAN M, 1993, J CELL SCI, V105, P1025
[4]   ABNORMAL EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN CUTANEOUS EPITHELIAL TUMORS [J].
GROVES, RW ;
ALLEN, MH ;
MACDONALD, DM .
JOURNAL OF CUTANEOUS PATHOLOGY, 1992, 19 (01) :66-72
[5]   A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA-CELLS [J].
GUNTHERT, U ;
HOFMANN, M ;
RUDY, W ;
REBER, S ;
ZOLLER, M ;
HAUSSMANN, I ;
MATZKU, S ;
WENZEL, A ;
PONTA, H ;
HERRLICH, P .
CELL, 1991, 65 (01) :13-24
[6]  
GUTTINGER M, 1995, EUR J DERMATOL, V5, P398
[7]   Distribution of CD44 variant isoforms in human skin: Differential expression in components of benign and malignant epithelia [J].
Hale, LP ;
Patel, DD ;
Clark, RE ;
Haynes, BF .
JOURNAL OF CUTANEOUS PATHOLOGY, 1995, 22 (06) :536-545
[8]  
HAYNES BF, 1991, CANCER CELL-MON REV, V3, P347
[9]   Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway [J].
Hirao, M ;
Sato, N ;
Kondo, T ;
Yonemura, S ;
Monden, M ;
Sasaki, T ;
Takai, Y ;
Tsukita, S ;
Tsukita, S .
JOURNAL OF CELL BIOLOGY, 1996, 135 (01) :37-51
[10]   Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation [J].
Kaya, G ;
Rodriguez, I ;
Jorcano, JL ;
Vassalli, P ;
Stamenkovic, I .
GENES & DEVELOPMENT, 1997, 11 (08) :996-1007